MEDPACE HOLDINGS INC

NASDAQ: MEDP (Medpace Holdings, Inc.)

Last update: yesterday, 8:30PM

590.09

-1.23 (-0.21%)

Previous Close 591.32
Open 588.44
Volume 184,581
Avg. Volume (3M) 319,051
Market Cap 16,656,434,176
Price / Earnings (TTM) 41.15
Price / Earnings (Forward) 36.90
Price / Sales 7.56
Price / Book 56.52
52 Weeks Range
250.05 (-57%) — 625.00 (5%)
Earnings Date 22 Oct 2025
Profit Margin 19.31%
Operating Margin (TTM) 20.32%
Diluted EPS (TTM) 13.10
Quarterly Revenue Growth (YOY) 9.30%
Quarterly Earnings Growth (YOY) 11.70%
Total Debt/Equity (MRQ) 25.33%
Current Ratio (MRQ) 0.730
Operating Cash Flow (TTM) 581.97 M
Levered Free Cash Flow (TTM) 433.28 M
Return on Assets (TTM) 15.44%
Return on Equity (TTM) 65.82%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Medpace Holdings, Inc. Bullish Bullish

AIStockmoo Score

-0.4
Analyst Consensus -1.5
Insider Activity -1.5
Price Volatility -3.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average -0.40

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MEDP 17 B - 41.15 56.52
IDXX 57 B - 56.18 35.29
NTRA 28 B - - 22.78
ILMN 16 B - 12.85 7.83
ICLR 13 B - 22.75 1.33
EXAS 13 B - - 5.04

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Growth
% Held by Insiders 20.55%
% Held by Institutions 91.47%

Ownership

Name Date Shares Held
Mawer Investment Management Ltd. 30 Sep 2025 646,774
52 Weeks Range
250.05 (-57%) — 625.00 (5%)
Price Target Range
450.00 (-23%) — 655.00 (11%)
High 655.00 (Mizuho, 11.00%) Buy
Median 479.50 (-18.74%)
Low 450.00 (Jefferies, -23.74%) Hold
Average 521.00 (-11.71%)
Total 1 Buy, 3 Hold, 2 Sell
Avg. Price @ Call 562.29
Firm Date Target Price Call Price @ Call
BMO Capital 13 Nov 2025 600.00 (1.68%) Hold 591.32
Barclays 24 Oct 2025 485.00 (-17.81%) Sell 605.20
02 Oct 2025 425.00 (-27.98%) Sell 536.17
Mizuho 24 Oct 2025 655.00 (11.00%) Buy 605.20
17 Oct 2025 575.00 (-2.56%) Buy 528.07
TD Cowen 24 Oct 2025 462.00 (-21.71%) Sell 605.20
Jefferies 09 Sep 2025 450.00 (-23.74%) Hold 485.59
Rothschild & Co 03 Sep 2025 474.00 (-19.67%) Hold 481.23
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
GEIGER JESSE J - 598.81 -21,503 -12,876,211
Aggregate Net Quantity -21,503
Aggregate Net Value ($) -12,876,211
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 598.81
Name Holder Date Type Quantity Price Value ($)
GEIGER JESSE J Officer 05 Nov 2025 Automatic sell (-) 21,503 598.81 12,876,211

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria